Results

Total Results: 1,636 records

Showing results for "treating".

181. Cad-Pci-Bypass Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
     May 01, 2013 - CER #9: Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease Original release date: October 2007 Surveillance Report: May 2013 Key Findings: - New RCT and cohort studies further delineate which patients have improved outcome…

182. Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension – An Update of the 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research-protocol

183. Disposition of Comments for CER 176 Management of Gout (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
     March 15, 2016 - , many gout experts will take issue with the statement that "the strength of evidence is low that treating … We agree that if the reviewer accepts that treating to a specific target is appropriate therapy, then … (if they are treating at all!) … As well, unlike treating blood pressure (too low can cause side effects) or blood sugar (too low can … These data might support or refute a “preventive” argument for treating hyperuricemia, as opposed to

184. Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
     December 01, 2017 - Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary Comparative Effectiveness Review Number 202 Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma Evidence Summary Objectives and Rationale for Review This report summarizes a systematic review, “E…

185. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - In December 2012, FDA approved teduglutide for treating adults with SBS who require nutritional support … period, one patient required 20 mm balloon dilatation 1 month after POEM, which was successful in treating … Gattex®]) is intended to provide several critical actions throughout the gastrointestinal tract for treating … In December 2012, FDA approved teduglutide for treating adults with SBS who require additional nutrition

186. Pneumonia-Antibiotic-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
     November 01, 2014 - It is a severe type of HAP; because of the difficulty in treating it, its prognosis can be poor. … developing severe HAP; in these cases, clinicians should treat them in ways similar to those used for treating … antibiotic therapy significantly improves survival for patients with HAP.8-11 Relevant antibiotics for treating … speaking, given the unique attributes of the lung that contribute to the challenge of adequately treating

187. Strategies to Treat and Manage Infantile Hemangioma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/infantile-hemangioma/research-protocol

188. Medicines To Treat Alcohol Use Disorder | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/consumer

189. Major-Depressive-Disorder Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
     December 01, 2015 - psychotherapies in clinical practice, further research into their comparative effectiveness with SGAs in treating … extend to the comparative effectiveness of SGAs and both psychological and CAM interventions for treating … outcomes for patients with MDD, especially because treatment continuity is one of the main challenges in treating … Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder

190. Protocol for Quantitative Assessment of Benefit and Harm analysis of Aspirin for primary prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research.pdf
     February 01, 2014 - Angiotensin- Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating … Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating

191. Quantitative Synthesis: Chapter 2. Presenting Different Effects for Different Data Types (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-2.pdf
     February 01, 2018 - Quantitative Synthesis: Chapter 2. Presenting Different Effects for Different Data Types Quantitative Synthesis Chapter 2. Presenting Different Effects for Different Data Types Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Systematic Reviews Methods Guide www.ahrq.gov …

192. Disposition of Comments_Comparative Effectiveness Review No. 271, Treatments for Maternal Mental Health Conditions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-271-mental-health-pregnant-disposition-comments.pdf
     July 31, 2024 - interventions were not expected to be interventions of interest, since they are typically not aimed at treating … were deemed to have the primary aim of teaching parenting skills rather than the primary aim of treating … There is evidence that CBT, IPT, exercise, and behavioral activation are effective treatments for treating … am disappointed to not see more information about EMDR, which has been proven very effective at treating … practice that cares for pregnant families must have first line providers spend time assessing and treating

193. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - In December 2012, FDA approved teduglutide for treating adults with SBS who require nutritional support … Gattex®]) is intended to provide several critical actions throughout the gastrointestinal tract for treating … In December 2012, FDA approved the drug for treating adults with SBS who require additional nutrition … experts commented that this the drug could reduce the amount of health care resources required for treating

194. Phenylketonuria Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
     February 01, 2012 - that is reported as fulfilled is an open-label study to study the safety and efficacy of BH4 for treating

195. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - In December 2012, FDA approved teduglutide for treating adults with SBS who require nutritional support … Gattex®]) is intended to provide several critical actions throughout the gastrointestinal tract for treating … In December 2012, FDA approved the drug for treating adults with SBS who require additional nutrition … experts commented that this the drug could reduce the amount of health care resources required for treating

196. Topic-Brief3-Sud (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief3-SUD.pdf
     April 01, 2021 - buprenorphine) or opioid antagonist effects (naltrexone) are considered first-line treatment.25 In addition to treating … involve continuation of medications for opioid use disorder (including partial or full agonists) while treating … Treating perioperative and acute pain in patients on buprenorphine: narrative literature review and … Opioid analgesics play an essential role in treating pain, and pain management in the context of the … continuation of the medication for opioid use disorder (including partial of full agonists) while treating

197. Topic-Brief3-Sud (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
     April 01, 2021 - buprenorphine) or opioid antagonist effects (naltrexone) are considered first-line treatment.25 In addition to treating … involve continuation of medications for opioid use disorder (including partial or full agonists) while treating … Treating perioperative and acute pain in patients on buprenorphine: narrative literature review and … Opioid analgesics play an essential role in treating pain, and pain management in the context of the … continuation of the medication for opioid use disorder (including partial of full agonists) while treating

198. C-Diff-Infections-Surveillance-140925 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
     January 01, 2014 - , and colestipol are not more effective in treating CDI than standard antibiotic treatment with oral … Treating recurrent CDI Level of Evidence: Low There is limited evidence from two case series that … fecal flora reconstitution is effective in treating recurrent CDI for up to 1 year. … Treating CDI, active control Probiotics, prebiotics, C. difficile immune whey, and colestipol are … Do Not Know fecal flora reconstitution is effective in treating recurrent CDI for up to 1 year.

199. Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/policymaker

200. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
     January 01, 2012 - In May 2012, the FDA’s Arthritis Advisory Committee recommended approval of tofacitinib for treating … Regence, United Healthcare, Wellmark) found that 5 list coverage determinations for MSC therapy for treating … symptoms of the disease. 24 PRP has been used in a number of hemostatic applications as well as for treating … inhibitor that is being investigated as a targeted disease-modifying antirheumatic drug (DMARD) for treating … 52 In May 2012, the Arthritis Advisory Committee to FDA recommended approval of tofacitinib for treating